业务
货币单位:EUR
2023/FY
名称营收比例
Service delivery and clinical stage research, notably into potential therapies in the areas of1,747.7万100.00%
地区
货币单位:EUR
2023/FY
名称营收比例
日本1,275万72.95%
中国461万26.38%
法国11.8万0.68%